Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of subcutaneous insulin pump, insulin glargine, and NPH insulin in children aged 0 to 6 years with type 1 diabetes
2007-005212-41Phase 4Active
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin glargine, insulin isophane and insulin lispro in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Sant Joan de Déu Hospital. Primary endpoints: Metabolic control, Quality of life and 1 more. Started Dec 2007; status: active.
02
Drugs
insulin glargineinsulin isophaneinsulin lispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2007-005212-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005212-41.